Rongfeng Holding Group Co.,Ltd. (SZSE:000668) intends to acquire Wuhu Dongxu Weiyu Medical Device Technology Co., Ltd. from a group of shareholders on July 8, 2020. As of November 9, 2020, Rongfeng Holding signed Share Transfer Agreement to acquire 30.15% stake in Anhui Weiyu from Shengshida Investment. At the same time, Rongfeng Holding will carry out a private placement to raise supporting funds not exceeding CNY 440 million. Rongfeng Holding Group Co.,Ltd. will issue shares in consideration. As of July 20, 2021, Shengshida Investment transferred 30.15% stake to Rongfeng Holding Group. As of December 31, 2019, Wuhu Dongxu Weiyu Medical Device Technology Co., Ltd. has total assets of CNY 1.3 billion, owner?s equity of CNY 755.7 million, operating revenue of CNY 1.5 billion, operating profit of CNY 184.4 million and net profit of CNY 138.6 million. Transaction is subject to Rongfeng Holding Group Co.,Ltd. board of directors approval, The shareholders' general meeting of Rongfeng Holding Group Co.,Ltd. needs to review and approve the relevant proposals of the transaction, China Securities Regulatory Commission approval and the transaction plan has passed the internal decision-making process of the counterparties. On June 5, 2020, Wuhu Dongxu Weiyu Medical Device Technology Co Ltd. held a shareholders' meeting and reviewed and approved the bill related to the transaction. On November 9, 2020, Rongfeng Holding Group Co.,Ltd. held the 22nd Meeting of the 9th Directorate, and approved the transaction. On November 9, 2020, Anhui Weiyu Medical Equipment Technology Co., Ltd. held a shareholders meeting, and approved the transaction. As of October 18, 2021, Rongfeng Holding Group Co.,Ltd. still needs to pay transfer price of approximately CNY 160 million. ZTF Securities Co., Ltd., King & Wood Mallesons, China acted as legal advisor and ZTF Securities Co., Ltd. acted as financial advisor to Rongfeng Holding.